Unipharm 2000-AD, Sofia to merge into Unipharm AD, Sofia. This proposal will be voted by the shareholders of the two companies slated for 25 June, an announcement published in today’s issue of the State Official Gazette shows.

In case no quorum is present at the meeting, it is to be rescheduled for 10 July 2007. According to data from the APIS system Unipharm 2000 controls 90.85% from the capital of Unipharm AD.

Last year the shareholders of Unipharm decided to increase the company’s capital and to list it on the Bulgarian Stock Exchange.

The company is a producer of medicines, it operates in the field of scientific research and experiments in new medicine production technologies in Bulgaria, etc.